Mathew R Williams MD

PubMed

• 4 citations
  Use and performance of the evolut FX transcatheter aortic valve system.
  Tanvir Bajwa, Guilherme F Attizzani, Hemal Gada, Stanley J Chetcuti, Mathew R Williams
  Cardiovascular Revascularization Medicine. 2024-10-01
• One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk Patients.
  S Chris Malaisrie, Mayra Guerrero, Charles Davidson, Mathew Williams, Fábio Sândoli de Brito Jr
  Circulation. Cardiovascular Interventions. 2024-08-01
• 2 citations
  Impact of heart failure hospitalizations on clinical outcomes after mitral transcatheter edge-to-edge repair: Results from the EXPAND study.
  Mirjam Kessler, Wolfgang Rottbauer, Ralph Stephan von Bardeleben, Carmelo Grasso, Philipp Lurz
  European Journal of Heart Failure. 2024-07-01

Journal Articles

• Outcomes After Transcatheter Aortic Valve Replacement in Patients with Low Versus High Gradient Severe Aortic Stenosis in the Setting of Preserved Left Ventricular Eje...  
  Cezar Staniloae, Ricardo Benenstein, Umair Jangda, Muhamed Saric, Mathew R Williams, Daniel McDonald, Alan Vainrib, Robert Donnino, Journal of Interventional Cardiology

Lectures

• Optimum Transcatheter Aortic Valve: Global First-in-Human 
  CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
• Technology Description and Clinical Data 
  CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
• OPTIMUM TAV First-In-Human Results 
  CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019